First Trust Advisors
PTX

First Trust Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

First Trust Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,471
Closed -$53K – 2368
2013
Q2 		$53K Buy
+1,471
New +$55.1K ﹤0.01% 2200

Other funds holding PTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors's PTX Position: Q3 2013 in Review

First Trust Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2013, closing a stake of 1,471 shares — an estimated $53K sold.

First Trust Advisors first reported a position in PTX in Q2 2013 and held it in 1 quarter. The position peaked at $53K in Q2 2013. 45 funds tracked by Wall St. Rank hold PTX as of Q3 2013.

  • First Trust Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2013 after selling out during the quarter.
  • First Trust Advisors sold 1,471 Pernix Therapeutics Holdings, Inc. shares in Q3 2013, an estimated $53K.
  • First Trust Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 1 quarter.
  • First Trust Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $53K in Q2 2013.
  • 45 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2013.

Based on First Trust Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.